Albert Fiori was diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy or CIDP, a rare autoimmune disease that affects his eye, one arm and one leg. But he is not letting that stop him from ...

A 64-year-old woman in Mumbai has been diagnosed with Guillain-Barre Syndrome, marking the city's first case of this rare nerve disorder. After being hospitalized with fever and ascending paralysis, ...

Barré Syndrome (GBS), a rare nerve disorder, in a 64-year-old woman. The patient, who resides in Andheri east, was ...

MUMBAI: The tally of Guillain Barre Syndrome (GBS) cases in Maharashtra has reached 189, while the first GBS-suspected patient from Andheri-East was detect ...

Mumbai reported its first case of Guillain-Barre Syndrome (GBS) on Friday after a 64-year-old woman was diagnosed with the rare nerve disorder, civic officials said. GBS is a rare condition in which a ...

Guggenheim Securities adjusted its price target for Immunovant shares, listed on (NASDAQ:IMVT), to $44.00, a decrease from the previous $46.00, while sustaining a Buy rating on the stock. Currently ...

H.C. Wainwright reaffirmed their Buy rating on Immunovant (NASDAQ:IMVT) shares with a price target of $51.00, aligning with the broader Wall Street sentiment. According to InvestingPro data, analyst ...

The tally of suspected Guillain-Barré syndrome (GBS) cases in the Pune region has reached 180, with the detection of seven ...

KBC Group NV boosted its position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 60.1% in the 4th quarter, ...

Mumbai reported its first case of Guillain-Barré syndrome on Friday after a 64-year-old woman was diagnosed with the rare ...